权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Identification of enzymes inhibited by oncometabolites in Succinate Dehydrogenase mutant tumors

琥珀酸脱氢酶突变肿瘤中癌代谢物抑制的酶的鉴定

基本信息

批准号：
10579575
负责人：
Lawrence S Kirschner
金额：
$ 7.88万
依托单位：
OHIO STATE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-01-01 至 2024-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10579575
关键词：
Acute Myelocytic Leukemia Aerobic Affect Biological Models CRISPR interference CRISPR/Cas technology Cancer Etiology Cell Line Cell model Cell physiology Cells Cellular Metabolic Process Characteristics Citric Acid Cycle Clear Cell Clustered Regularly Interspaced Short Palindromic Repeats Collagen Correlative Study DNA DNA Modification Process Data Data Set Disease Elderly Endocrine Enzyme Inhibition Enzymes Epithelium Eukaryotic Cell Familiarity Family Family member Fumarate Hydratase Future Gastrointestinal Stromal Tumors Generations Genes Genetic Glioblastoma Glioma Hereditary Paraganglioma Histones Human Hydroxylation In Vitro Inherited Investigation Isocitrate Dehydrogenase Knowledge Lead Lesion Light Localized Disease Malate Dehydrogenase Malignant Neoplasms Malignant neoplasm of thyroid Mediating Metabolic Missense Mutation Mitochondrial Proteins Mixed Function Oxygenases Modeling Molecular Mutation Neoplasms Nuclear Oncogenic Operative Surgical Procedures Oxygenases Paraganglioma Patients Phenotype Pheochromocytoma Process Production Property Protein Isoforms Proteins Quality of life RNA Reactive Oxygen Species Renal Cell Carcinoma Renal carcinoma Reporting Research Project Grants Role Somatic Mutation Source Structural Protein Study models Succinate Dehydrogenase Succinates Survival Rate Syndrome System Thyroid Gland Time Tissues Tumor Promotion United States United States National Institutes of Health Validation Variant Work aldehyde dehydrogenases alpha ketoglutarate cofactor gene repression high risk histone demethylase in silico in vivo in vivo Model knock-down leukemia member mouse model mutant neoplastic small hairpin RNA stem stem cell biomarkers stem cells therapy development transcription factor tumor tumorigenesis

项目摘要

PROJECT SUMMARY The tricarboxylic acid cycle (TCA cycle, also known as the Krebs cycle) is a fundamental process in eukaryotic cells, serving as the source for ATP generation and producing reducing equivalents for cell metabolism under aerobic conditions. In recent years, it has become clear that genes encoding the enzymes in the TCA cycle can be causative genetic lesions in human cancers, including in inherited tumor syndromes associated with renal cancer, paragangliomas/pheochromocytomas (PPGL), and Gastrointestinal Stromal Tumors (GISTs) among others, including epithelial thyroid cancer. They are also well described in sporadic tumors from these same tissues, as well as in a spectrum of other cancers, including acute myeloid leukemia (AML) and glioblastoma. Mutations in Krebs cycle enzymes and their related cofactors are thought to cause tumor formation through the oncogenic effects of excess metabolite accumulation (oncometabolites). These intermediate metabolites act by interference with the function of enzymes requiring the metabolic cofactor alpha-ketoglutarate (aKG, also known as 2- oxoglutarate). There are approximately 70 aKG-dependent enzymes in humans, and they perform a variety of essential cellular functions, including mediating modification of DNA, RNA, and histone proteins. Enzymes of this class are also responsible for oxidative hydroxylation of proteins, including the structural protein collagen. We have previously demonstrated using both in vitro and in vivo models for thyroid neoplasia that loss of the Succinate Dehydrogenase D subunit (SDHD) causes phenotypic changes indicative of early stages of cancer. Further, this genetic changes causes cells to gain a stem-like phenotype, as evidenced by expression of the stem cell associated transcription factors Nanog and Oct4 and production of the stem cell marker Aldehyde Dehydrogenase (ALDH). Despite the fact that interference with aKG-dependent oxygenases has been proposed as a neoplastic mechanism, no prior efforts have been made to identify family members which are responsible for the neoplastic change. To fill this knowledge gap, we propose to use a high throughput CRISPR-based transcriptional repression screen to identify aKG-dependent enzymes whose inhibition leads to a recapitulation of the stem-like phenotype. Identified hits will be validated using a combination of cellular models and in silico analysis of tumor-based omics data. The Aims for this R03 pilot proposal are as follows: 1) To use a CRISPRi screen to identify alpha-ketoglutarate (aKG) dependent enzyme(s) whose inhibition leads to the acquisition of a stem-like phenotype 2) To validate identified enzymes in cell line models and in human tumor datasets Identification of the enzymes whose functions are affected by accumulation of the oncometabolite succinate will shed important new light on the molecular mechanism of disease associated with Sdhx and other TCA cycle mutations, and will provide a stepping stone for future research grants that will allow detailed delineation of genetic and/or protein targets that drive tumor formation in the thyroid and other tissues (e.g. glioma, leukemia).

项目总结